The trials plaguing the medicinal cannabis market
New Zealand's medicinal cannabis industry faces hurdles. Puro, a successful cultivator, exports to the UK due to restrictive domestic regulations, including packaging requirements. Tim Aldridge is pushing for regulatory changes. High local standards, designed to ensure quality, increase costs for patients, according to Sally King. There is hope for relaxed regulations in the future.
